<?xml version="1.0" encoding="UTF-8"?>
<ref id="B115-viruses-12-00862">
 <label>115.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kimoto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sakai</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kido</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice</article-title>
  <source>Vaccine</source>
  <year>2019</year>
  <volume>37</volume>
  <fpage>612</fpage>
  <lpage>622</lpage>
  <pub-id pub-id-type="pmid">30553569</pub-id>
 </element-citation>
</ref>
